{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:30:34Z","timestamp":1791419434109,"version":"4.3.3"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-alcoholic fatty liver disease (NAFLD) is recognized as a liver manifestation of metabolic syndrome, accompanied with excessive fat accumulation in the liver and other vital organs. Ectopic fat accumulation was previously associated with negative effects at the systemic and local level in the human body. Thus, we aimed to identify and assess the predictive capability of novel potential metabolic biomarkers for ectopic fat depots in non-diabetic men with NAFLD, using the inflammation-associated proteome, lipidome and metabolome. Myocardial and hepatic triglycerides were measured with magnetic spectroscopy while function of left ventricle, pericardial and epicardial fat, subcutaneous and visceral adipose tissue were measured with magnetic resonance imaging. Measured ectopic fat depots were profiled and predicted using a Random Forest algorithm, and by estimating the Area Under the Receiver Operating Characteristic curves. We have identified distinct metabolic signatures of fat depots in the liver (TAG50:1, glutamate, diSM18:0 and CE20:3), pericardium (N-palmitoyl-sphinganine, HGF, diSM18:0, glutamate, and TNFSF14), epicardium (sphingomyelin, CE20:3, PC38:3 and TNFSF14), and myocardium (CE20:3, LAPTGF-\u03b21, glutamate and glucose). Our analyses highlighted non-invasive biomarkers that accurately predict ectopic fat depots, and reflect their distinct metabolic signatures in subjects with NAFLD.<\/jats:p>","DOI":"10.1038\/s41598-018-31865-w","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T07:17:35Z","timestamp":1537168655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome"],"prefix":"10.1038","volume":"8","author":[{"given":"Alen","family":"Lovric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Gran\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Bjornson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Benfeitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"St\u00e5hlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku O.","family":"Pentik\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Lundbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-2532","authenticated-orcid":false,"given":"Antti","family":"Hakkarainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-6145","authenticated-orcid":false,"given":"Reijo","family":"Sir\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku S.","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Lundbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Lauerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Riitta","family":"Taskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Mardinoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-8091","authenticated-orcid":false,"given":"Jan","family":"Boren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"31865_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2010","unstructured":"Dowman, J. K., Tomlinson, J. W. & Newsome, P. N. Pathogenesis of non-alcoholic fatty liver disease. QJM: monthly journal of the Association of Physicians 103, 71\u201383, https:\/\/doi.org\/10.1093\/qjmed\/hcp158 (2010).","journal-title":"QJM: monthly journal of the Association of Physicians"},{"key":"31865_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65, 1038\u20131048, https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012 (2016).","journal-title":"Metabolism"},{"key":"31865_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang, P. L. A comprehensive definition for metabolic syndrome. Disease models & mechanisms 2, 231\u2013237, https:\/\/doi.org\/10.1242\/dmm.001180 (2009).","journal-title":"Disease models & mechanisms"},{"key":"31865_CR4","first-page":"9","volume":"13","author":"P Paschos","year":"2009","unstructured":"Paschos, P. & Paletas, K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 13, 9\u201319 (2009).","journal-title":"Hippokratia"},{"key":"31865_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep27034","volume":"6","author":"KC Yang","year":"2016","unstructured":"Yang, K. C. et al. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance. Sci Rep 6, 27034, https:\/\/doi.org\/10.1038\/srep27034 (2016).","journal-title":"Sci Rep"},{"key":"31865_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","volume":"33","author":"LS Bhatia","year":"2012","unstructured":"Bhatia, L. S., Curzen, N. P., Calder, P. C. & Byrne, C. D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur. Heart J. 33, 1190\u20131200 (2012).","journal-title":"Eur. Heart J."},{"key":"31865_CR7","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","volume":"20","author":"H Liu","year":"2014","unstructured":"Liu, H. & Lu, H. Y. Nonalcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol 20, 8407\u20138415, https:\/\/doi.org\/10.3748\/wjg.v20.i26.8407 (2014).","journal-title":"World J Gastroenterol"},{"issue":"1","key":"31865_CR8","doi-asserted-by":"publisher","first-page":"e001979","DOI":"10.1161\/circimaging.114.001979","volume":"8","author":"M. Graner","year":"2014","unstructured":"Graner, M. et al. Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circulation. Cardiovascular imaging 8, https:\/\/doi.org\/10.1161\/circimaging.114.001979 (2015).","journal-title":"Circulation: Cardiovascular Imaging"},{"key":"31865_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1172\/JCI10947","volume":"107","author":"HC Chiu","year":"2001","unstructured":"Chiu, H. C. et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107, 813\u2013822, https:\/\/doi.org\/10.1172\/JCI10947 (2001).","journal-title":"J Clin Invest"},{"key":"31865_CR10","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1210\/jc.2006-0584","volume":"91","author":"M Kankaanpaa","year":"2006","unstructured":"Kankaanpaa, M. et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91, 4689\u20134695, https:\/\/doi.org\/10.1210\/jc.2006-0584 (2006).","journal-title":"J Clin Endocrinol Metab"},{"key":"31865_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1210\/jc.2012-3190","volume":"98","author":"M Graner","year":"2013","unstructured":"Graner, M. et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab 98, 1189\u20131197, https:\/\/doi.org\/10.1210\/jc.2012-3190 (2013).","journal-title":"J Clin Endocrinol Metab"},{"key":"31865_CR12","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2009-0436","volume":"94","author":"P Iozzo","year":"2009","unstructured":"Iozzo, P. et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 94, 4472\u20134482, https:\/\/doi.org\/10.1210\/jc.2009-0436 (2009).","journal-title":"J Clin Endocrinol Metab"},{"key":"31865_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","volume":"116","author":"JM McGavock","year":"2007","unstructured":"McGavock, J. M. et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116, 1170\u20131175, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.645614 (2007).","journal-title":"Circulation"},{"key":"31865_CR14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","volume":"52","author":"LJ Rijzewijk","year":"2008","unstructured":"Rijzewijk, L. J. et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. Journal of the American College of Cardiology 52, 1793\u20131799, https:\/\/doi.org\/10.1016\/j.jacc.2008.07.062 (2008).","journal-title":"Journal of the American College of Cardiology"},{"key":"31865_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.echo.2010.09.007","volume":"23","author":"L Ernande","year":"2010","unstructured":"Ernande, L. et al. Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J Am Soc Echocardiogr 23, 1266\u20131272, https:\/\/doi.org\/10.1016\/j.echo.2010.09.007 (2010).","journal-title":"J Am Soc Echocardiogr"},{"issue":"14","key":"31865_CR16","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1177\/2047487317717820","volume":"24","author":"Regitse H Christensen","year":"2017","unstructured":"Christensen, R. H. et al. Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Eur J Prev Cardiol 2047487317717820, https:\/\/doi.org\/10.1177\/2047487317717820 (2017).","journal-title":"European Journal of Preventive Cardiology"},{"key":"31865_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.yjmcc.2012.06.018","volume":"55","author":"PC Kienesberger","year":"2013","unstructured":"Kienesberger, P. C., Pulinilkunnil, T., Nagendran, J. & Dyck, J. R. Myocardial triacylglycerol metabolism. J Mol Cell Cardiol 55, 101\u2013110, https:\/\/doi.org\/10.1016\/j.yjmcc.2012.06.018 (2013).","journal-title":"J Mol Cell Cardiol"},{"key":"31865_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1532-429X-15-103","volume":"15","author":"K Nyman","year":"2013","unstructured":"Nyman, K. et al. Cardiac steatosis and left ventricular function in men with metabolic syndrome. J Cardiovasc Magn Reson 15, 103, https:\/\/doi.org\/10.1186\/1532-429X-15-103 (2013).","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6352","key":"31865_CR19","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"Mathias Uhlen","year":"2017","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357 https:\/\/doi.org\/10.1126\/science.aan2507 (2017).","journal-title":"Science"},{"key":"31865_CR20","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419, https:\/\/doi.org\/10.1126\/science.1260419 (2015).","journal-title":"Science"},{"issue":"6340","key":"31865_CR21","doi-asserted-by":"publisher","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","volume":"356","author":"Peter J. Thul","year":"2017","unstructured":"Thul, P. J. et al. A subcellular map of the human proteome. Science 356, https:\/\/doi.org\/10.1126\/science.aal3321 (2017).","journal-title":"Science"},{"key":"31865_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cmet.2016.05.026","volume":"24","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance. Cell Metab 24, 172\u2013184, https:\/\/doi.org\/10.1016\/j.cmet.2016.05.026 (2016).","journal-title":"Cell Metab"},{"key":"31865_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.numecd.2015.11.002","volume":"26","author":"M Graner","year":"2016","unstructured":"Graner, M. et al. Biomarkers and prediction of myocardial triglyceride content in non-diabetic men. Nutr Metab Cardiovasc Dis 26, 134\u2013140, https:\/\/doi.org\/10.1016\/j.numecd.2015.11.002 (2016).","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"31865_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal, L. F., Mertens, I. L. & De Block, C. E. Mechanisms linking obesity with cardiovascular disease. Nature 444, 875\u2013880, https:\/\/doi.org\/10.1038\/nature05487 (2006).","journal-title":"Nature"},{"key":"31865_CR25","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1161\/CIRCULATIONAHA.111.077602","volume":"124","author":"KA Britton","year":"2011","unstructured":"Britton, K. A. & Fox, C. S. Ectopic fat depots and cardiovascular disease. Circulation 124, e837\u2013841, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.077602 (2011).","journal-title":"Circulation"},{"key":"31865_CR26","doi-asserted-by":"publisher","first-page":"e0151301","DOI":"10.1371\/journal.pone.0151301","volume":"11","author":"P Wolf","year":"2016","unstructured":"Wolf, P. et al. Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans. PLoS One 11, e0151301, https:\/\/doi.org\/10.1371\/journal.pone.0151301 (2016).","journal-title":"PLoS One"},{"key":"31865_CR27","doi-asserted-by":"publisher","first-page":"e43502","DOI":"10.1371\/journal.pone.0043502","volume":"7","author":"U Lim","year":"2012","unstructured":"Lim, U. et al. Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women. PLoS One 7, e43502, https:\/\/doi.org\/10.1371\/journal.pone.0043502 (2012).","journal-title":"PLoS One"},{"key":"31865_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep43782","volume":"7","author":"N Morrice","year":"2017","unstructured":"Morrice, N. et al. Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice. Sci Rep 7, 43782, https:\/\/doi.org\/10.1038\/srep43782 (2017).","journal-title":"Sci Rep"},{"key":"31865_CR29","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J Clin Invest 115, 1627\u20131635, https:\/\/doi.org\/10.1172\/JCI23606 (2005).","journal-title":"J Clin Invest"},{"key":"31865_CR30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","volume":"139","author":"J Dushay","year":"2010","unstructured":"Dushay, J. et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 139, 456\u2013463, https:\/\/doi.org\/10.1053\/j.gastro.2010.04.054 (2010).","journal-title":"Gastroenterology"},{"key":"31865_CR31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang, X. et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57, 1246\u20131253, https:\/\/doi.org\/10.2337\/db07-1476 (2008).","journal-title":"Diabetes"},{"issue":"1","key":"31865_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.yexcr.2017.05.006","volume":"360","author":"Eleftheria Maratos-Flier","year":"2017","unstructured":"Maratos-Flier, E. Fatty liver and FGF21 physiology. Exp Cell Res, https:\/\/doi.org\/10.1016\/j.yexcr.2017.05.006 (2017).","journal-title":"Experimental Cell Research"},{"key":"31865_CR33","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-15-0289","volume":"227","author":"P Tanajak","year":"2015","unstructured":"Tanajak, P., Chattipakorn, S. C. & Chattipakorn, N. Effects of fibroblast growth factor 21 on the heart. J Endocrinol 227, R13\u201330, https:\/\/doi.org\/10.1530\/JOE-15-0289 (2015).","journal-title":"J Endocrinol"},{"key":"31865_CR34","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1210\/jc.2009-0111","volume":"94","author":"C Christodoulides","year":"2009","unstructured":"Christodoulides, C., Dyson, P., Sprecher, D., Tsintzas, K. & Karpe, F. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J Clin Endocrinol Metab 94, 3594\u20133601, https:\/\/doi.org\/10.1210\/jc.2009-0111 (2009).","journal-title":"J Clin Endocrinol Metab"},{"key":"31865_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","volume":"8","author":"C Galman","year":"2008","unstructured":"Galman, C. et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab 8, 169\u2013174, https:\/\/doi.org\/10.1016\/j.cmet.2008.06.014 (2008).","journal-title":"Cell Metab"},{"key":"31865_CR36","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1210\/jc.2004-0603","volume":"89","author":"ME Trujillo","year":"2004","unstructured":"Trujillo, M. E. et al. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab 89, 5577\u20135582, https:\/\/doi.org\/10.1210\/jc.2004-0603 (2004).","journal-title":"J Clin Endocrinol Metab"},{"key":"31865_CR37","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek, T. et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108, 2460\u20132466, https:\/\/doi.org\/10.1161\/01.CIR.0000099542.57313.C5 (2003).","journal-title":"Circulation"},{"key":"31865_CR38","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/oby.2009.343","volume":"18","author":"TM Tadros","year":"2010","unstructured":"Tadros, T. M. et al. Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity (Silver Spring) 18, 1039\u20131045, https:\/\/doi.org\/10.1038\/oby.2009.343 (2010).","journal-title":"Obesity (Silver Spring)"},{"key":"31865_CR39","doi-asserted-by":"publisher","first-page":"e0133494","DOI":"10.1371\/journal.pone.0133494","volume":"10","author":"S Sindhu","year":"2015","unstructured":"Sindhu, S. et al. Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PLoS One 10, e0133494, https:\/\/doi.org\/10.1371\/journal.pone.0133494 (2015).","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"31865_CR40","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay, C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 8(Suppl 2), S3, https:\/\/doi.org\/10.1186\/ar1917 (2006).","journal-title":"Arthritis Res Ther"},{"key":"31865_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI1368","volume":"101","author":"Z Xing","year":"1998","unstructured":"Xing, Z. et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101, 311\u2013320, https:\/\/doi.org\/10.1172\/JCI1368 (1998).","journal-title":"J Clin Invest"},{"issue":"43","key":"31865_CR42","first-page":"22","volume":"200","author":"F Alrashed","year":"2018","unstructured":"Alrashed, F., Kochumon, S., Tuomilehto, J., Sindhu, S. & Ahmad, R. Elevated adipose tissue expression of CCL19 in obese individuals with or without type-2 diabetes: Its association with metabolic inflammation. The Journal of Immunology 200(43), 22\u201343.22 (2018).","journal-title":"The Journal of Immunology"},{"key":"31865_CR43","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/oby.21127","volume":"23","author":"T Sano","year":"2015","unstructured":"Sano, T. et al. Protection from diet-induced obesity and insulin resistance in mice lacking CCL19-CCR7 signaling. Obesity (Silver Spring) 23, 1460\u20131471, https:\/\/doi.org\/10.1002\/oby.21127 (2015).","journal-title":"Obesity (Silver Spring)"},{"key":"31865_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ijo.2009.199","volume":"34","author":"J Bassols","year":"2010","unstructured":"Bassols, J., Moreno-Navarrete, J. M., Ortega, F., Ricart, W. & Fernandez-Real, J. M. LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes. Int J Obes (Lond) 34, 146\u2013156, https:\/\/doi.org\/10.1038\/ijo.2009.199 (2010).","journal-title":"Int J Obes (Lond)"},{"key":"31865_CR45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.febslet.2011.01.011","volume":"585","author":"HM Kim","year":"2011","unstructured":"Kim, H. M., Jeong, C. S., Choi, H. S., Kawada, T. & Yu, R. LIGHT\/TNFSF14 enhances adipose tissue inflammatory responses through its interaction with HVEM. FEBS Lett 585, 579\u2013584, https:\/\/doi.org\/10.1016\/j.febslet.2011.01.011 (2011).","journal-title":"FEBS Lett"},{"key":"31865_CR46","doi-asserted-by":"publisher","unstructured":"Subramanian, V. & Ferrante, A. W., Jr. Obesity, inflammation, and macrophages. Nestle Nutr Workshop Ser Pediatr Program 63 151\u2013159; discussion 159\u2013162, 259\u2013168, https:\/\/doi.org\/10.1159\/000209979 (2009).","DOI":"10.1159\/000209979"},{"key":"31865_CR47","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1172\/JCI2293","volume":"101","author":"JA Levine","year":"1998","unstructured":"Levine, J. A., Jensen, M. D., Eberhardt, N. L. & O\u2019Brien, T. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest 101, 1557\u20131564, https:\/\/doi.org\/10.1172\/JCI2293 (1998).","journal-title":"J Clin Invest"},{"key":"31865_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12986-016-0095-9","volume":"13","author":"X Gao","year":"2016","unstructured":"Gao, X. et al. Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals. Nutr Metab (Lond) 13, 33, https:\/\/doi.org\/10.1186\/s12986-016-0095-9 (2016).","journal-title":"Nutr Metab (Lond)"},{"key":"31865_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.14348\/molcells.2015.0126","volume":"38","author":"S Park","year":"2015","unstructured":"Park, S., Sadanala, K. C. & Kim, E. K. A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes. Mol Cells 38, 587\u2013596, https:\/\/doi.org\/10.14348\/molcells.2015.0126 (2015).","journal-title":"Mol Cells"},{"key":"31865_CR50","doi-asserted-by":"publisher","first-page":"805683","DOI":"10.1155\/2012\/805683","volume":"2012","author":"B Xie","year":"2012","unstructured":"Xie, B., Waters, M. J. & Schirra, H. J. Investigating potential mechanisms of obesity by metabolomics. J Biomed Biotechnol 2012, 805683, https:\/\/doi.org\/10.1155\/2012\/805683 (2012).","journal-title":"J Biomed Biotechnol"},{"key":"31865_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix036","volume":"6","author":"H Zhong","year":"2017","unstructured":"Zhong, H. et al. Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals. Gigascience 6, 1\u201312, https:\/\/doi.org\/10.1093\/gigascience\/gix036 (2017).","journal-title":"Gigascience"},{"key":"31865_CR52","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/nutd.2014.32","volume":"4","author":"H Nakamura","year":"2014","unstructured":"Nakamura, H. et al. Plasma amino acid profiles are associated with insulin, C-peptide and adiponectin levels in type 2 diabetic patients. Nutr Diabetes 4, e133, https:\/\/doi.org\/10.1038\/nutd.2014.32 (2014).","journal-title":"Nutr Diabetes"},{"key":"31865_CR53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1532-5415.2011.03865.x","volume":"60","author":"R Ramachandran","year":"2012","unstructured":"Ramachandran, R. et al. Selective contribution of regional adiposity, skeletal muscle, and adipokines to glucose disposal in older adults. J Am Geriatr Soc 60, 707\u2013712, https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03865.x (2012).","journal-title":"J Am Geriatr Soc"},{"key":"31865_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9, 311\u2013326, https:\/\/doi.org\/10.1016\/j.cmet.2009.02.002 (2009).","journal-title":"Cell Metab"},{"key":"31865_CR55","unstructured":"Henstridge, D. & Bozaoglu, K. In Adiposity - Omics and Molecular Understanding (ed Jan Oxholm Gordeladze) Ch. 02 (InTech, 2017)."},{"key":"31865_CR56","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000365040","volume":"64","author":"S Rauschert","year":"2014","unstructured":"Rauschert, S., Uhl, O., Koletzko, B. & Hellmuth, C. Metabolomic biomarkers for obesity in humans: a short review. Ann Nutr Metab 64, 314\u2013324, https:\/\/doi.org\/10.1159\/000365040 (2014).","journal-title":"Ann Nutr Metab"},{"key":"31865_CR57","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1371\/journal.pone.0000218","volume":"2","author":"KH Pietilainen","year":"2007","unstructured":"Pietilainen, K. H. et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects\u2013a monozygotic twin study. PLoS One 2, e218, https:\/\/doi.org\/10.1371\/journal.pone.0000218 (2007).","journal-title":"PLoS One"},{"key":"31865_CR58","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1210\/jc.2015-3525","volume":"101","author":"S Rauschert","year":"2016","unstructured":"Rauschert, S. et al. Lipidomics Reveals Associations of Phospholipids With Obesity and Insulin Resistance in Young Adults. J Clin Endocrinol Metab 101, 871\u2013879, https:\/\/doi.org\/10.1210\/jc.2015-3525 (2016).","journal-title":"J Clin Endocrinol Metab"},{"key":"31865_CR59","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1038\/nutd.2014.38","volume":"4","author":"H Hanamatsu","year":"2014","unstructured":"Hanamatsu, H. et al. Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults. Nutr Diabetes 4, e141, https:\/\/doi.org\/10.1038\/nutd.2014.38 (2014).","journal-title":"Nutr Diabetes"},{"key":"31865_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","volume":"688","author":"CR Gault","year":"2010","unstructured":"Gault, C. R., Obeid, L. M. & Hannun, Y. A. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 688, 1\u201323 (2010).","journal-title":"Adv Exp Med Biol"},{"key":"31865_CR61","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","volume":"64","author":"PK Luukkonen","year":"2016","unstructured":"Luukkonen, P. K. et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol 64, 1167\u20131175, https:\/\/doi.org\/10.1016\/j.jhep.2016.01.002 (2016).","journal-title":"J Hepatol"},{"key":"31865_CR62","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin, S. M. et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab 20, 678\u2013686, https:\/\/doi.org\/10.1016\/j.cmet.2014.08.002 (2014).","journal-title":"Cell Metab"},{"key":"31865_CR63","doi-asserted-by":"publisher","first-page":"e41456","DOI":"10.1371\/journal.pone.0041456","volume":"7","author":"MN Barber","year":"2012","unstructured":"Barber, M. N. et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One 7, e41456, https:\/\/doi.org\/10.1371\/journal.pone.0041456 (2012).","journal-title":"PLoS One"},{"key":"31865_CR64","doi-asserted-by":"publisher","first-page":"e111348","DOI":"10.1371\/journal.pone.0111348","volume":"9","author":"S Heimerl","year":"2014","unstructured":"Heimerl, S. et al. Alterations of plasma lysophosphatidylcholine species in obesity and weight loss. PLoS One 9, e111348, https:\/\/doi.org\/10.1371\/journal.pone.0111348 (2014).","journal-title":"PLoS One"},{"key":"31865_CR65","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","volume":"56","author":"M Oresic","year":"2013","unstructured":"Oresic, M. et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia 56, 2266\u20132274, https:\/\/doi.org\/10.1007\/s00125-013-2981-2 (2013).","journal-title":"Diabetologia"},{"key":"31865_CR66","doi-asserted-by":"publisher","first-page":"e85724","DOI":"10.1371\/journal.pone.0085724","volume":"9","author":"A Sigruener","year":"2014","unstructured":"Sigruener, A. et al. Glycerophospholipid and sphingolipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. PLoS One 9, e85724, https:\/\/doi.org\/10.1371\/journal.pone.0085724 (2014).","journal-title":"PLoS One"},{"key":"31865_CR67","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee, E. P. et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121, 1402\u20131411, https:\/\/doi.org\/10.1172\/JCI44442 (2011).","journal-title":"J Clin Invest"},{"key":"31865_CR68","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/oby.21448","volume":"24","author":"KT Tonks","year":"2016","unstructured":"Tonks, K. T. et al. Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans. Obesity (Silver Spring) 24, 908\u2013916, https:\/\/doi.org\/10.1002\/oby.21448 (2016).","journal-title":"Obesity (Silver Spring)"},{"key":"31865_CR69","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640\u20131645, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644 (2009).","journal-title":"Circulation"},{"key":"31865_CR70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499\u2013502 (1972).","journal-title":"Clin Chem"},{"key":"31865_CR71","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace, T. M., Levy, J. C. & Matthews, D. R. Use and abuse of HOMA modeling. Diabetes care 27, 1487\u20131495 (2004).","journal-title":"Diabetes care"},{"key":"31865_CR72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/jmre.1997.1244","volume":"129","author":"L Vanhamme","year":"1997","unstructured":"Vanhamme, L., van den Boogaart, A. & Van Huffel, S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129, 35\u201343 (1997).","journal-title":"J Magn Reson"},{"key":"31865_CR73","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1194\/jlr.D023036","volume":"53","author":"L Lofgren","year":"2012","unstructured":"Lofgren, L. et al. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J Lipid Res 53, 1690\u20131700, https:\/\/doi.org\/10.1194\/jlr.D023036 (2012).","journal-title":"J Lipid Res"},{"key":"31865_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbalip.2005.12.007","volume":"1761","author":"G Liebisch","year":"2006","unstructured":"Liebisch, G. et al. High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS\/MS). Biochim Biophys Acta 1761, 121\u2013128, https:\/\/doi.org\/10.1016\/j.bbalip.2005.12.007 (2006).","journal-title":"Biochim Biophys Acta"},{"key":"31865_CR75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ab.2007.03.012","volume":"366","author":"RC Murphy","year":"2007","unstructured":"Murphy, R. C. et al. Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal Biochem 366, 59\u201370, https:\/\/doi.org\/10.1016\/j.ab.2007.03.012 (2007).","journal-title":"Anal Biochem"},{"key":"31865_CR76","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1021\/ac060545x","volume":"78","author":"CS Ejsing","year":"2006","unstructured":"Ejsing, C. S. et al. Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal Chem 78, 6202\u20136214, https:\/\/doi.org\/10.1021\/ac060545x (2006).","journal-title":"Anal Chem"},{"key":"31865_CR77","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1073\/pnas.0811700106","volume":"106","author":"CS Ejsing","year":"2009","unstructured":"Ejsing, C. S. et al. Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. Proc Natl Acad Sci USA 106, 2136\u20132141, https:\/\/doi.org\/10.1073\/pnas.0811700106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"31865_CR78","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.18632\/oncotarget.6808","volume":"7","author":"IM Di Gangi","year":"2016","unstructured":"Di Gangi, I. M. et al. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites. Oncotarget 7, 5815\u20135829, https:\/\/doi.org\/10.18632\/oncotarget.6808 (2016).","journal-title":"Oncotarget"},{"key":"31865_CR79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Machine Learning 45, 5\u201332, https:\/\/doi.org\/10.1023\/A:1010933404324 (2001).","journal-title":"Machine Learning"},{"key":"31865_CR80","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1037\/a0016973","volume":"14","author":"C Strobl","year":"2009","unstructured":"Strobl, C., Malley, J. & Tutz, G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods 14, 323\u2013348, https:\/\/doi.org\/10.1037\/a0016973 (2009).","journal-title":"Psychol Methods"},{"key":"31865_CR81","first-page":"627","volume":"4","author":"K Hajian-Tilaki","year":"2013","unstructured":"Hajian-Tilaki, K. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med 4, 627\u2013635 (2013).","journal-title":"Caspian J Intern Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31865-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:51:30Z","timestamp":1671598290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31865-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31865"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31865-w","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734059638.793558319","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"assertion":[{"value":"14 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14200"}}